File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treatment options for postmenopausal osteoporosis in asia

TitleTreatment options for postmenopausal osteoporosis in asia
Authors
KeywordsBone mineral density
Fracture
Osteoporosis
Postmenopausal
Treatment
Issue Date2008
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrd
Citation
International Journal Of Rheumatic Diseases, 2008, v. 11 n. 4, p. 386-392 How to Cite?
AbstractTreatment of osteoporosis has advanced dramatically during the past decade, with more therapeutic options than ever now available. Large-scale randomized placebo-controlled trials have documented the efficacy of a number of agents in reducing vertebral and non-vertebral fractures. Anti-resorptive agents (hormone replacement therapy, selective estrogen-receptor modulators, calcitonin and bisphosphonates) and bone-forming anabolic agents (parathyroid horomone and strontium ranelate) act via different mechanisms to reduce fractures and improve bone strength. In view of the high prevalence of calcium and vitamin D insufficiency in Asia, calcium and vitamin D supplementation remains a fundamental part of any treatment regimen, especially among the elderly. Given the high cost of these agents, a global assessment of the fracture risk of the patient is essential to determine the need for pharmacological treatment versus life-style modification and dietary supplementation in the management of postmenopausal osteoporosis in Asia. © 2008 Asia Pacific League of Associations for Rheumatology.
Persistent Identifierhttp://hdl.handle.net/10722/59370
ISSN
2015 Impact Factor: 1.914
2015 SCImago Journal Rankings: 0.536
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChu, EYWen_HK
dc.contributor.authorTsang, SWYen_HK
dc.contributor.authorKung, AWCen_HK
dc.date.accessioned2010-05-31T03:48:36Z-
dc.date.available2010-05-31T03:48:36Z-
dc.date.issued2008en_HK
dc.identifier.citationInternational Journal Of Rheumatic Diseases, 2008, v. 11 n. 4, p. 386-392en_HK
dc.identifier.issn1756-1841en_HK
dc.identifier.urihttp://hdl.handle.net/10722/59370-
dc.description.abstractTreatment of osteoporosis has advanced dramatically during the past decade, with more therapeutic options than ever now available. Large-scale randomized placebo-controlled trials have documented the efficacy of a number of agents in reducing vertebral and non-vertebral fractures. Anti-resorptive agents (hormone replacement therapy, selective estrogen-receptor modulators, calcitonin and bisphosphonates) and bone-forming anabolic agents (parathyroid horomone and strontium ranelate) act via different mechanisms to reduce fractures and improve bone strength. In view of the high prevalence of calcium and vitamin D insufficiency in Asia, calcium and vitamin D supplementation remains a fundamental part of any treatment regimen, especially among the elderly. Given the high cost of these agents, a global assessment of the fracture risk of the patient is essential to determine the need for pharmacological treatment versus life-style modification and dietary supplementation in the management of postmenopausal osteoporosis in Asia. © 2008 Asia Pacific League of Associations for Rheumatology.en_HK
dc.languageengen_HK
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrden_HK
dc.relation.ispartofInternational Journal of Rheumatic Diseasesen_HK
dc.subjectBone mineral densityen_HK
dc.subjectFractureen_HK
dc.subjectOsteoporosisen_HK
dc.subjectPostmenopausalen_HK
dc.subjectTreatmenten_HK
dc.titleTreatment options for postmenopausal osteoporosis in asiaen_HK
dc.typeArticleen_HK
dc.identifier.emailKung, AWC:awckung@hku.hken_HK
dc.identifier.authorityKung, AWC=rp00368en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/j.1756-185X.2008.00389.xen_HK
dc.identifier.scopuseid_2-s2.0-70349492398en_HK
dc.identifier.hkuros159054en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-70349492398&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume11en_HK
dc.identifier.issue4en_HK
dc.identifier.spage386en_HK
dc.identifier.epage392en_HK
dc.identifier.isiWOS:000266391800011-
dc.publisher.placeAustraliaen_HK
dc.identifier.scopusauthoridChu, EYW=26666500500en_HK
dc.identifier.scopusauthoridTsang, SWY=35182014900en_HK
dc.identifier.scopusauthoridKung, AWC=7102322339en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats